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Abstract Low-molecular-mass copper(lI) species have been de- 
tected and quantified in ultrafiltrates (n = 7) of rheumatoid syn- 
ovial fluid (SF) by a highly-sensitive HPLC-based assay system 
with the ability to determine Cu(II) concentrations of < 10 -7 
mol.dm -3. High field 1H NMR spectroscopy demon- 
strated that addition of Cu(II)¢,q.) to isolated samples of RA SF 
ultrafiltrates resulted in complexation by histidine > alanine > 
formate > threouine > lactate • tyrosine • phenylalauine, their 
effectiveness in this context being in the given order. CD spectra 
of Cu(H)-treated samples of intact SF exhibited absorption bands 
typical of copper(II)-albumin complexes, in addition to a band 
attributable to a low-molecular-mass histidinate complex (A~ 
610 nm). Since both albumin and histidine are potent radical 
scavengers, these results indicate that any "OH radical generated 
from bound copper ions will be 'site-specifically' scavenged. 
ttence, low-molecular-mass copper complexes with the ability to 
promote the generation of "OH radical which can then escape 
trom the metal ion co-ordination sphere (and in turn, cause dam- 
age to critical biomolecules) appear to be absent from inflamma- 
tory SF. 
dey words: Low-molecular-mass copper; Inflammatory joint 
disease; HPLC; JH NMR; Speculation; Synovial fluid 
i. Introduction 
Much debate has taken place regarding the involvement of 
, ,xygen-derived free-radical species in the pathogenesis of in- 
flammatory joint diseases [1,2]. It is now well established that 
nflammation increases plasma levels of caeruloplasmin, an 
acute-phase' cuproprotein with associated antioxidant activity 
3,4]. The higher antioxidant activity of the blood serum of 
~atients uffering from rheumatoid arthritis (RA) relative to 
'hat of control serum has been attributed to the elevated level 
~f caeruloplasmin present in the former [5]. 
Copper(II) species are known to exert deleterious effects in 
~hysiological environments. Indeed, copper ions have been im- 
)licated in mediating the production of oxygen-derived free 
adical species in vivo [6]. Caschin [7] has reported that the 
abile Cu(II) complex of glycylglycine causes an erosive 
trthropathy in guinea pigs, and has speculated that this may 
trise from the Cu(II) chelate-catalysed generation of oxygen- 
lerived free radical species within the joint. Moreover, the 
:opper ion-catalysed generation of hydrogen peroxide (H202) 
"rom homocysteine has been shown to give rise to endothelial 
cell injury, and an equivalent detrimental effect is caused by 
.:aeruloplasmin i  the presence of homocysteine [8]. 
"Corresponding author. Fax: (44) (171) 377 7677. 
Copper(II) complexes of many anti-inflammatory com- 
pounds have exhibited enhanced therapeutic activity, relative 
to the parent ligands, in selected model systems [9-12]. Further- 
more, in two models of acute inflammation (carrageenan-in- 
duced foot pad oedema nd pleurisy), a copper deficiency was 
found to exert a pro-inflammatory effect [13]. However, using 
the 'phenanthroline assay', attempts to detect copper ions in a 
form which promotes the generation of "OH or 'crypto-'OH' 
radical species in fresh serum or SF collected from patients with 
RA have been unsuccessful [14]. 
Some anti-rheumatic drugs, including glucocorticosteroids, 
oligomeric 1 : 1 gold(I)-thiolate complexes and D-penicillamine, 
have been associated with lowered serum copper levels [15,16]. 
In male Wistar rats, administration of disodium aurothioma- 
late resulted in a significant reduction in the serum levels of 
copper with a corresponding five-fold increase in kidney copper 
deposition [16]. Gold(I)-thiolate complexes and D-penicillamine 
have been hypothesised to reduce total biofluid copper levels 
via their interaction with Cu(II) ions bound to the N-terminal 
binding site located on albumin [15]. A mixture of histidine, 
cysteine and Cu(II) ions has been demonstrated to mimic diso- 
dium aurothiomalate in inhibiting the sulphydryl-disulfide in-
terchange reaction-mediated denaturation of human gamma 
globulin, bovine serum albumin and diluted human serum [17]. 
In view of the controversy associated with the role of Cu(II) 
complexes in rheumatoid arthritis, we have investigated the 
chemical nature of a number of Cu(II) species present in iso- 
lated RA SF samples. Moreover, we report for the first time 
the detection and quantification of trace levels (ca. 10 -7 
mol'dm -3) of copper ions in ultrafiltrates of this bio- 
fluid by a novel high performance liquid chromatographic 
(HPLC) method. These studies are of particular elevance to 
the pro- and/or anti-inflammatory properties of Cu(II) species 
in RA, and the mode of action of potential anti-inflammatory 
copper ion complexes. 
2. Materials and methods 
2.l. Reagents 
Acetic acid, methanol, and sodium acetate were obtained from BDH 
Chemicals Ltd (Poole, Dorset, UK). Ammonium acetate and tetrabu- 
tylammonium bromide were purchased from Aldrich Chemical Co 
(Poole, Dorset, UK). Analytical grade CuC12-2H20 was obtained 
from Hopkin and Williams Ltd. (Chadwell Heath, Essex, UK), 
and 2-(5-Bromo-2-pyridylazo)- 5-(N-propyl-N-sulphopropyl-amino)- 
phenol (5-Br-PAPS) was purchased from Dojindo Chemical Co. 
(Japan). Distilled and de-ionised water (ELGA maxima water purifier) 
was utilised throughout these investigations. 
2.2. Biofluid samples 
Synovial fluid was aspirated for therapeutic reasons from the knee- 
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joints of patients (n = 7) attending a rheumatology clinic who had been 
previously diagnosed as having RA as assessed according to the criteria 
of the American Rheumatism Association (ARA). RA sera (n = 7) were 
obtained in a similar manner. Control serum samples (n = 7) were 
obtained from normal healthy human volunteers. Biofluid samples 
were centrifuged at 7,000 ×g for 15 min in order to remove cells and 
cell debris, and where required, ultrafiltered at 5,000 × g for 30 min 
using Millipore ultrafiltration devices with a membrane molecular 
weight cut-offof5 kDa. All centrifugations were performed at 5°C. For 
the quantification of copper ion in inflammatory synovial fluid, serum 
and control normal serum ultrafiltrates by HPLC, samples were centri- 
fuged and ultrafiltered within 1 h of aspiration. 
2.3. NMR measurements 
NMR spectra were recorded at a probe temperature of 25°C on a 
JEOL JNM-GSX 500 spectrometer operating in quadrature detection 
mode at 500.16 MHz for tH. Typically, 0.60 ml of each SF ultrafiltrate 
sample was placed in a 5-mm diameter NMR tube, and 0.07 ml of 2H20 
was added to provide a field frequency lock. For intact biofluid sam- 
pies, the broad protein resonances were suppressed by the Hahn spin- 
echo pulse sequence D[90°x-t-180°y-t-collect], where t - -60 ms. 
Pulsing conditions for single-pulse spectra were: 45 ° pulse angle, 2.730 
s acquisition time, 2.270 s pulse delay, 32,768 computer points and 128 
transients. Chemical shifts were referenced to external sodium 3-(tri- 
methylsilyl)-[1,1,2,2-d4]-propionate (d = 0.00 ppm). The intense H20 
signal was suppressed by the application of secondary irradiation at the 
water frequency. Microlitre aliquot additions of a 1.0 × 10 -2 mol. dm -3 
aqueous olution of copper(II) chloride were made using a pre-cali- 
brated micropipette. 
2.4. Ion-pair reversed-phase high performance liquid chromatographic" 
analysis of copper(ll) in biofluid ultrafiltrate samples 
Synovial fluid ultrafiltrates (0.38 ml) were treated with 10 ,ul of 
ammonium acetate buffer (1.00 mol. dm -3, pH 3.80). The Cu(II) ion- 
chelating pre-column derivatising agent 5-Br-PAPS (10 ,ul of a 
5.00 × 10 -3 mol.dm -3 aqueous olution) was added and the resulting 
solution thoroughly mixed. The sample was then heated in stoppered 
tubes at 95°C on a water bath for a period of 20 min to allow equilibra- 
tion and, on cooling, 20/11 aliquots were used for HPLC analysis. 
HPLC analysis was performed with an Applied Chromatography 
Systems 351 isocratic pump coupled to a Rheodyne injector fitted with 
a 20/A loop. Detection was made using an ACS 750/16 variable wave- 
length detector coupled to an SE 120 chart recorder. Detection was 
monitored at a wavelength of 570 nm, using a flow-rate of 0.6 ml/min 
with a methanol/water [70:30 (v/v)] eluant containing 1.00× 10 -4 
mol.dm -3 5-Br-PAPS, 1.00× 10 -2 mol.dm -3 sodium acetate 
and 5.00 × 10 2 mol. dm -3 tetrabutylammonium bromide (ion-pair ea- 
gent). The eluant was buffered to pH 3.90 prior to the addition of 
methanol. A Spherisorb S5-ODS 1 column (250 mm × 4.5 mm) was 
employed in conjunction with a Spherisorb S5-ODS 1 guard column. 
2.5. Cireular dichroism spectroscopy 
CD measurements were performed using quartz cells (1 cm) on a 
JASCO J600 spectrophotometer operating at ambient temperature. 
3. Results 
The HPLC-based method for the determination of low-mo- 
lecular-mass (ultrafilterable) copper ions in biofluids described 
Table 1 
Levels of copper ions in normal healthy human serum and rheumatoid 
arthritic knee-joint synovial fluid and sera 
Control Rheumatoid Rheumatoid 
sera sera synovial fluid 
n 7 7 7 
Mean age years 36 60 50 
(2846) (47-67) (22 76) 
Ultrafilterable copper* 3.45 _+ 1.62 2.59 + 1.28 1.25 + 0.95 
(× 10 -7 mol.dm -3) (1.5 5.6) (0.0t~5.1) (0.0C~3.0) 
*Mean + S.D. 
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Fig. 1. HPLC analysis of copper(II) ions in isolated rheumatoid syno- 
vial fluid using 5-Br-PAPS as chromophore. A methanol/water (70 : 30, 
v/v) mobile phase was employed with a flow-rate of 0.60 ml/min. Detec- 
tion was at 570 nm. 
herein was developed and utilised since previously available 
assay systems do not appear to provide the sensitivity required 
for such investigations (ca. -< 1 × 10 -7 mol. dm-3). Analysis of 
Cu(II) in fresh RA SF and serum ultrafiltrate samples by this 
method revealed the presence of low-molecular-mass copper 
ion species in 6 out of a total of 7 samples examined (Fig. 1 and 
Table I). The mean copper ion concentrat ion for SF was 
1.25 + 0.95 × 10 -7 mol .dm -3 (mean + standard eviation) and 
for RA sera was 2.59 + 1.28 × 10 -7 mol 'dm -3. The mean cop- 
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l ig. 2. Visible absorption spectra of RA SF ultrafiltrate before (A), and 
t~ fter addition of Cu(lI)~,q) at a concentration f 2.50 x 10 -4 tool. dm -3 
-4  ' -3  I B), and 5.00 x10 tool.din- (C). 
t,er ion concentration for normal control sera was 
:.45 + 1.62 x 10 -7 mol.dm -3, a value which is comparable to 
previously reported levels [18] and significantly higher than that 
,,f RA serum (P < 0.05) and SF (P < 0.01) (one-way analysis- 
,,f-variance (ANOVA) performed on untransformed data; fur- 
1her comparisons of sample group means were made using 
!'ukey's test). Doubly-distilled water, together with relevant 
buffer and reagent solutions erved as control samples for this 
method and no copper ions were detectable therein. Data ac- 
quired on rheumatoid knee-joint SF samples are therefore at 
the lower limit of sensitivity for assays utilised previously for 
he detection of oxygen radical-generating low-molecular-mass 
, opper ion species in RA SF. Without any form of pre-concen- 
ration, this assay system has the ability to detect copper ions 
,~t a lower limit of 5 x 10 -8 mol.dm 3. 
2.000E+01 . . . . . . .  = . . . . . . . .  
Visible electronic absorption spectrophotometry was em- 
ployed to primarily establish the molecular nature of the low- 
molecular-weight copper species present in RA SF. Fig. 2 
shows the visible absorption spectrum of RA SF ultrafiltrate 
to which has been added increasing concentrations of aqueous 
copper(II) chloride. As expected, the visible absorption spec- 
trum of RA SF ultrafiltrate exhibited no distinct features. Ad- 
dition of increasing levels of Cu(ll)~aq.) to these ultrafiltrates 
gave rise to the development of a broad band with a ~'max value 
of ca. 610 nm which was the major feature of all samples 
investigated. Previous investigations have established that this 
absorption band is characteristic of copper(II)-histidinate 
chelates [19]. No other absorption bands were detectable 
throughout the entire wavelength range investigated. 
Circular dichroism (CD) spectra of rheumatoid synovial 
fluid ultrafiltrate samples exhibited no major features. How- 
ever, the addition of Cu(II)(~q.) (5.00 × 10 -3 mol' dm -3) to these 
ultrafiltrates resulted in the appearance of an absorption mini- 
mum with a "~min value of ca. 610 nm (Fig. 3), again character- 
istic of low-molecular-mass copper(lI)-histidinate complexes 
[19]. As expected, CD spectra of cell-free, intact rheumatoid 
synovial fluids exhibited no characteristic features. However, 
addition of Cu(lI)(aq.~ to these samples resulted in albumin- 
binding of this transition metal ion, a phenomenon revealed by 
the appearance of absorption minima and maxima located at 
wavelengths of ca. 320, 400, 410 and 575 nm. Furthermore, a 
broad shoulder located at ca. 610 nm in these spectra is indic- 
ative of the presence of low-molecular-mass Cu(lI)-histidinate 
species [19]. 
Further useful information concerning the chemical nature 
of low-molecular-mass copper(II) complexes present in inflam- 
matory SFs was provided by high field ~H NMR spectroscopy. 
The 500 MHz 'H NMR spectrum of a typical isolated RA SF 
ultrafiltrate sample is shown in Fig. 4a. Equilibration of these 
macromolecule-free samples with increasing sequential concen- 
trations of Cu(II)~,q.) for a period of I h at ambient temperature 
A 
CD [mdeg]  r~. . . . , , .~_  ~ . . . . . . .  ~ _ . . ~  . 
Bilirubin 
• "¢'---' Cu-Histidine 
Cu-Albumin 
-2 .000E+01 . . . . . . .  a ,  . . . . . . . .  , . . . . . .  , , , I , , , , , , , , 
320 .0  700 .0  
Wave length  [nm]  
ffig. 3. Circular dichroism spectra of (A) RA SF ultrafiltrate; (A1) as (A), but after the addition of 5.00 x 10 -3 mol.dm -3 Cu(II)CI2; (B) intact RA 
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Fig. 4. 500 MHz ~H NMR spectra of (a) RA SF ultrafiltrate, and the same sample following equilibration with Cu(II) at concentrations of 
(b) 1.40 x I0 -s and (c) 7.20 x I0 -s tool.din -3. Abbreviations: A, acetate-CH3; Ac, acetone-CH~; Ala, alanine-CH3; Cit, citrate-CH2; Cn', creatine 
N-CH3; Glc, glucose ring protons; Form, formate-H; His, histidine imidazo|e ring protons; Lac-CH3 and CH, lactate-CH 3 and CH groups; Phen, 
phenylalanine aromatic ring protons; Thr, threonine-CH~; Tyr, tyrosine aromatic ring protons; Val, valine-CH3 group. 
gave rise to the line-broadening of selected resonances present 
in their spectra. At an added Cu(I1) concentration of 
1.43 × 10 -5 tool. dm -3, complexation by histidine occurs result- 
ing in the complete disappearance of its imidazole ring proton 
resonances from the spectrum. This selective removal of the 
histidine C2H and C4H imidazole ring proton resonances re- 
flects the powerful Cu(lI) chelating ability of this amino acid 
[19]. At this concentration of added Cu(II), the intensity of the 
formate resonance (6 = 8.46 ppm) also diminished and an unas- 
signed resonance located at 7.98 ppm disappeared from the 
spectrum. In the high field spectral region, corresponding re- 
ductions in the intensities of the alanine and threonine reso- 
nances were readily detectable. Further addition of Cu(II) (to 
a total concentration 7.15 x 10 -5 tool.din -3) gave rise to a total 
broadening of the alanine and threonine methyl group doublet 
signals, indicative of their involvement in complexation of this 
metal ion. Indeed, at this level of added Cu(II), resonances in
the aromatic region were completely removed from the spec- 
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trum (an observation revealing further Cu(II) ion complexation 
by tyrosine and phenylalanine), whereas the line-widths of res- 
onances attributable to glucose, citrate and 3-o-hydroxybu- 
tyrate were not significantly influenced. At an added Cu(II) 
concentration of 2.86 x 10 -4 mol.dm -3, much broadening of 
resonances occurred throughout the entire spectrum. 
A typical proton Hahn spin-echo NMR spectrum of intact 
l,nacromolecule-containing) RA SF containing 1.00 x 10 -4 
Jaol-dm -3 added L-histidine is shown in Fig. 5. Incu- 
t,ation of this sample with Cu(lI)(aq.) (final concentration 
Jl.00 × 10 -4 mol-dm -3) for a period 1 h at ambient emperature 
~ esulted in a selective broadening of the imidazole ring proton 
~esonances of pre-added histidine (~ = 7.05 and 7.77 ppm), 
~adicating that this is a primary site for copper(II) ion chelation 
a inflammatory synovial fluids. Despite the addition of ex- 
, ,genous histidine to the intact RA SF sample, the intensity of 
'~he alanine-CH3 group doublet resonance is also significantly 
diminished after equilibration with Cu(II). Moreover, the 
ifighly-coupled glutamine fl- and 7/-CH2 group multiplets 
= 2.04 and 2.40 ppm) are completely removed from the spec- 
rum after treatment with this concentration of added Cu(II). 
~rolonged equilibration (12 h) of Cu(II)-loaded RA SF samples 
2.40 x 10 -4 mol" dm-3Cu(II)) with an excess of the hexadentate 
:helator EDTA (4.00 x 10 -4 mol-dm -3) had no effect on the 
ligh frequency (low field) region of spectra, (data not shown), 
lemonstrating that this powerful hexadentate chelator does not 
lave the capacity to remove Cu(II) ions chelated to endogenous 
listidine under the experimental conditions employed here. 
1. Discussion 
This investigation was specifically aimed at elucidating the 
9recise molecular nature of non-caeruloplasmin-bound Cu(II) 
His His 
species present in inflammatory SF samples, particularly low- 
molecular-mass complexes which reportedly promote the gen- 
eration of "OH radical in the presence of endogenous reduc- 
tants [1]. Our HPLC-based Cu(II) detection assay, based on the 
development and subsequent detection of a chromophoric 
Cu(II)-5-Br-PAPS complex [20], selectively detects and meas- 
ures low-molecular-mass Cu(II) in 'fresh' rheumatoid SF (anal- 
ysis was performed within 1 h of collection). Rapid analysis of 
fresh biofluid samples was necessary to prevent copper ion 
liberation from proteins via metalloproteinase activity. Addi- 
tion of metalloproteinase inhibitors such as EDTA or 1,10- 
phenanthroline precludes the accurate measurement of low- 
molecular-mass copper(II) since these reagents are powerful 
chelators of this metal ion. The differences observed between 
our results and those of previous investigations are explicable 
by the increase in sensitivity afforded by this technique. 
The complexation ofthis redox-active transition metal ion by 
albumin in biofluids is a well established phenomenon, and 
exchange of Cu(II) ions from albumin to low-molecular-mass 
chelators has been speculated to give rise to the re-distribution 
of Cu(II) species amongst further biofluid components, and 
also cells. The studies conducted here have provided much 
useful information concerning the nature of this process and 
the molecular nature of the species involved. In a previous 
computational study, a theoretical distribution of Cu(II) spe- 
cies has been determined from the stability constants for com- 
plexes of Cu(II) with amino acids present in blood plasma [21]. 
A major limitation of this approach, however, is its inability to 
incorporate proteins and peptides into the experimental models 
employed. In the experiments conducted here, such limitations 
are clearly circumvented. 
CD and visible absorption spectroscopic studies conducted 
on RA SF ultrafiltrates provided evidence for the complexation 
. . . . . . . . . . . . . . . . .  , . i . i . i . r . i . . ,  . J . . . . . . .  
ppm 8.0 7.0 4.0 3.0 2.0 1.0 
Fig. 5. 500 MHz IH Hahn spin-echo NMR spectra of RA SF containing added exogenous His (2.0 x 10 -4 mol-dm -3) (a), and the same sample 
following incubation with Cu(II) at a concentration of 1.0 x 10 4 mol. dm -3 (b). Abbreviations: as Fig. 4. 
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of added Cu(II) by histidine. Moreover, IH NMR studies per- 
formed on protein-free (ultrafiltered) synovial fluid demon- 
strated that complexation of added Cu(II) ion by the amino 
acids histidine and alanine predominates. This observation is
consistent with the calculated formation constant of 1017 for the 
ternary Cu(II). HisO.AlaO. species. Indeed, in the computa- 
tional speciation study of Furnival et al. [21], histidine was 
found to be incorporated in all copper(II)-amino acid com- 
plexes predicted to be present in the low-molecular-mass frac- 
tion of human blood plasma. 
Decreased serum histidine levels have been reported in pa- 
tients with rheumatoid arthritis [22]. However, with mean nor- 
mal and rheumatoid levels of 1.192× l0 -4 and 1.005× l0 -4 
mol- dm -3 respectively, little Cu(II) binding capacity 
is lost. Moreover, rheumatoid synovial fluid histidine levels 
have been reported to be higher than those of matched sera [23]. 
Previous studies have demonstrated that H202 attack on 
Cu(II)-histidine species generates four products: asparagine, 
aspartic acid, aspartylurea, nd formyl asparagine [24], prod- 
ucts which, to the best of our knowledge, do not display any 
pro-inflammatory properties. In addition, Cu(II)-histidinate 
complexes have been shown to exhibit superoxide dismutase 
(SOD)-mimetic activity [25]. The rate constant for the dismuta- 
tion of O'2- by Cu(II)-His species is of a similar order of mag- 
nitude to that of SOD itself. Further additions of Cu(II) solu- 
tions to rheumatoid SFs resulted in selective broadenings of the 
threonine, tyrosine and phenylalanine signals, the latter two 
aromatic amino-acids being effective hydroxyl radical scaven- 
gers (second order rate constants, k2 = 3.70 and 3.50× 10 9 
mol -~ .dm 3. s -~, respectively). 
CD and 1H Hahn spin-echo NMR experiments indicate that 
the protein fraction of intact SF complexes a large proportion 
of added Cu(II) ions. Addition of 2.00 x 10 -4 mol. dm -3 Cu(II) 
to intact synovial fluid resulted in only a marginal broadening 
of the IH NMR signals of low-molecular-mass components 
present in the spectrum. However, addition of these levels of 
added Cu(II) to protein-free RA SF ultrafiltrates gave rise to 
an extensive broadening of several resonances present in their 
spectra. The concentration of albumin in rheumatoid synovial 
fluid is ca. 3.1 x 10 -4 mol.dm -3 [26], facilitating binding of up 
to 100% of added Cu(II) ions. However, under the experimental 
conditions employed in this study, we detected Cu(II) ion com- 
plexation by histidine, indicating that significant quantities of 
added Cu(II) are chelated by this endogenous ligand. 
Of special relevance to this study is the ability of the Cu(II) 
complexes thus formed to exert either a therapeutic or deleteri- 
ous role in the inflammatory process. From previous work, 
Cu(II) bound to albumin is redox-active and participates in
mediating the generation of hydroxyl radical via interaction 
with hydrogen peroxide and superoxide. However, this process 
has been shown to result in oxidative damage only to albumin 
which effectively acts as a powerful "OH radical scavenger, i.e. 
a 'site-directed' scavenging of "OH radical by this protein. 
5. Conclusions 
Low levels of low-molecular-mass Cu(II) species were dem- 
onstrated to be present in 'fresh' rheumatoid synovial fluid. 
Using Hahn spin-echo 1H NMR, visible absorption and CD 
spectroscopies, we have demonstrated that Cu(II) associates 
with both protein and low-molecular-mass species in cell-free 
macromolecule-containing SF. Under the conditions em- 
ployed, we detected Cu(II) complexation by albumin and 
amino acids (specifically, histidine and alanine). In macromole- 
cule-free SF, very small quanties of Cu(II) were required to 
selectively and totally broaden the histidine resonances, indicat- 
ing its preferential complexation by this amino acid and reflect- 
ing the important role played by it in Cu(II) homeostasis n
vivo. 
These data are of significance in the design and screening of 
new Cu(II)-containing, and potential Cu(II)-chelating com- 
pounds as anti-inflammatory/anti-arthritic agents in vivo. Prior 
knowledge of the interactions of therapeutic agents with bio- 
fluid components i especially pertinent to the search for new 
drugs for the treatment of inflammatory diseases. 
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